Is MITPF or RYLD a better dividend investment in 2026?

MITPF currently yields 8.37% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between MITPF and RYLD?

MITPF has a forward dividend yield of 8.37% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 4.02 percentage points.

Home › Compare › MITPF vs RYLD

MITPF vs RYLD: Dividend Comparison 2026

MITPF yields 8.37% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $10.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MITPF

● Live price

8.37%

Share price

$23.90

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.8K

Annual income

$1,420.12

Full MITPF calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — MITPF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MITPF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MITPF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MITPF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MITPF

Annual income on $10K today (after 15% tax)

$711.30/yr

After 10yr DRIP, annual income (after tax)

$1,207.10/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, RYLD beats the other by $1,073.43/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MITPF + RYLD for your $10,000?

MITPF: 50%RYLD: 50%

100% RYLD50/50100% MITPF

Portfolio after 10yr

$40.0K

Annual income

$2,051.55/yr

Blended yield

5.12%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MITPF buys

RYLD buys

No recent congressional trades found for MITPF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMITPFRYLD

Forward yield	8.37%	12.39% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$34.8K	$45.3K ✓
Annual income after 10y	$1,420.12	$2,682.98 ✓
Total dividends collected	$11.3K	$19.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MITPF vs RYLD ($10,000, DRIP)

Year	MITPF Portfolio	MITPF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,537	$836.82	$11,939	$1,239.34	$402.00 → RYLD
2	$13,247	$902.27	$14,158	$1,382.89	$911.00 → RYLD
3	$15,142	$968.21	$16,682	$1,532.59	$1.5K → RYLD
4	$17,236	$1,034.35	$19,537	$1,687.64	$2.3K → RYLD
5	$19,543	$1,100.39	$22,752	$1,847.20	$3.2K → RYLD
6	$22,077	$1,166.04	$26,355	$2,010.43	$4.3K → RYLD
7	$24,854	$1,231.06	$30,376	$2,176.45	$5.5K → RYLD
8	$27,889	$1,295.21	$34,847	$2,344.43	$7.0K → RYLD
9	$31,199	$1,358.29	$39,800	$2,513.54	$8.6K → RYLD
10	$34,804	$1,420.12	$45,269	$2,682.98	$10.5K → RYLD

MITPF vs RYLD: Complete Analysis 2026

MITPF — Stock

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.

Full MITPF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this MITPF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MITPF vs SCHD MITPF vs JEPI MITPF vs O MITPF vs KO MITPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.